to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
A randomized, multicenter study comparing steroid-free immunosuppression and standard immunosuppression for liver transplant recipients with chronic hepatitis C.
Multicenter experience using telaprevir or boceprevir with peginterferon and ribavirin to treat hepatitis C genotype 1 after liver transplantation.
Interleukin-28B and fibrosing cholestatic hepatitis in posttransplant hepatitis C: a case-control study and literature review.
Mycophenolate and hepatitis C: salve on a wound or gasoline on a fire?
A practical guide to the management of HCV infection following liver transplantation.
Impact of immunosuppression and acute rejection on recurrence of hepatitis C: results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database.
Liver biopsy, viral kinetics, and the impact of viremia on severity of hepatitis C virus recurrence.
Approach to recurrent hepatitis C following liver transplantation.
Once-daily tacrolimus extended release formulation: experience at 2 years postconversion from a Prograf-based regimen in stable liver transplant recipients.
Impact of sirolimus and tacrolimus on mortality and graft loss in liver transplant recipients with or without hepatitis C virus: an analysis of the Scientific Registry of Transplant Recipients Database.
Reduction of immunosuppression for transplant-associated skin cancer: thresholds and risks.
Antibody-based immunosuppression following liver transplantation: the plot thickens.
Daclizumab induction therapy in liver transplant recipients with renal insufficiency.
Telaprevir, boceprevir, cytochrome P450 and immunosuppressive agents--a potentially lethal cocktail.
How important is acute cellular rejection?
Sirolimus as a calcineurin inhibitor- and renal-sparing agent: all good things come to those who wait versus spare the nephron, spoil the patient.
International Liver Transplantation Society Consensus Statement on Hepatitis C Management in Liver Transplant Recipients.
Everolimus Is Associated With Less Weight Gain Than Tacrolimus 2 Years After Liver Transplantation: Results of a Randomized Multicenter Study.
International Liver Transplantation Society Consensus Statement on Immunosuppression in Liver Transplant Recipients.